269 related articles for article (PubMed ID: 20946575)
1. Bisphosphonate use in conditions other than osteoporosis.
Silverman SL
Ann N Y Acad Sci; 2011 Feb; 1218():33-7. PubMed ID: 20946575
[TBL] [Abstract][Full Text] [Related]
2. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis.
Rizzoli R; Burlet N; Cahall D; Delmas PD; Eriksen EF; Felsenberg D; Grbic J; Jontell M; Landesberg R; Laslop A; Wollenhaupt M; Papapoulos S; Sezer O; Sprafka M; Reginster JY
Bone; 2008 May; 42(5):841-7. PubMed ID: 18314405
[TBL] [Abstract][Full Text] [Related]
3. Osteonecrosis of the jaw and bisphosphonates--putting the risk in perspective.
Bolland M; Hay D; Grey A; Reid I; Cundy T
N Z Med J; 2006 Dec; 119(1246):U2339. PubMed ID: 17151713
[TBL] [Abstract][Full Text] [Related]
4. Osteonecrosis of the jaw due to bisphosphonates.
Prescrire Int; 2008 Oct; 17(97):202-3. PubMed ID: 19536938
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates and osteonecrosis of the jaw.
Sambrook P; Olver I; Goss A
Aust Fam Physician; 2006 Oct; 35(10):801-3. PubMed ID: 17019456
[TBL] [Abstract][Full Text] [Related]
6. [Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis].
Chapurlat R; Meunier PJ
Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):743-51. PubMed ID: 10192126
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonate therapy and dental treatment.
Phillips G
J Mich Dent Assoc; 2009 Aug; 91(8):40, 42-5. PubMed ID: 19722373
[No Abstract] [Full Text] [Related]
8. [Bisphosphonate-associated osteonecrosis of the jaws 1].
Allard RH; Lips P; Eekhoff EM; van Merkesteyn JP; van der Waal I
Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):423-7. PubMed ID: 17972610
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations.
Radfar L; Masood F
J Okla Dent Assoc; 2008; 99(7):28-9. PubMed ID: 18595621
[TBL] [Abstract][Full Text] [Related]
10. A physician discusses the dental impact of oral bisphosphonates.
Roudebush CP
J Indiana Dent Assoc; 2006-2007 Winter; 85(4):4-5. PubMed ID: 17489111
[No Abstract] [Full Text] [Related]
11. Bisphosphonates, osteonecrosis, osteogenesis imperfecta and dental extractions: a case series.
Schwartz S; Joseph C; Iera D; Vu DD
J Can Dent Assoc; 2008; 74(6):537-42. PubMed ID: 18644240
[TBL] [Abstract][Full Text] [Related]
12. Implications of bisphosphonate use for the dentist: an introduction.
Kurtzman GM; Silverstein LH; Peden J; Shatz PC
Dent Today; 2006 Jun; 25(6):80, 82-5; quiz 85. PubMed ID: 16792113
[No Abstract] [Full Text] [Related]
13. Osteonecrosis of the jaw: balancing the benefits and risks of oral bisphosphonate treatment for osteoporosis.
Jeffcoat M; Watts NB
Gen Dent; 2008; 56(1):96-102; quiz 103-4, 111-2. PubMed ID: 18254568
[TBL] [Abstract][Full Text] [Related]
14. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
15. Osteonecrosis of the jaw.
Sambrook PN; Ebeling P
Curr Rheumatol Rep; 2008 Apr; 10(2):97-101. PubMed ID: 18460263
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate-related osteonecrosis of the jaw: an overview.
Ruggiero SL
Ann N Y Acad Sci; 2011 Feb; 1218():38-46. PubMed ID: 20946580
[TBL] [Abstract][Full Text] [Related]
17. Complication related to bisphosphonate therapy: osteonecrosis of the jaw.
Lee J
J Infus Nurs; 2009; 32(6):330-5. PubMed ID: 19918142
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients.
Hoff AO; Toth B; Hu M; Hortobagyi GN; Gagel RF
Ann N Y Acad Sci; 2011 Feb; 1218():47-54. PubMed ID: 20946574
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonate-induced necrosis of the jaws: a reconstructive nightmare.
Gevorgyan A; Enepekides DJ
Curr Opin Otolaryngol Head Neck Surg; 2008 Aug; 16(4):325-30. PubMed ID: 18626250
[TBL] [Abstract][Full Text] [Related]
20. Neridronic acid for the treatment of bone metabolic diseases.
Gatti D; Viapiana O; Idolazzi L; Fracassi E; Adami S
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1305-11. PubMed ID: 19761412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
